About

Peptide Science Desk is an independent, English-language publication for US readers. It covers peptide regulation, including FDA approvals, compounding lists, warning letters and PCAC meetings, along with registered clinical trials and the limits of the published evidence.

We cite primary sources: FDA, the Federal Register, ClinicalTrials.gov and PubMed. We do not sell peptides, publish dosing, or link to vendors. See our Editorial Policy and Advertising Policy.